Woodmont Investment Counsel LLC Raises Holdings in National Health Investors, Inc. $NHI

Woodmont Investment Counsel LLC increased its position in National Health Investors, Inc. (NYSE:NHI) by 7.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 103,817 shares of the real estate investment trust’s stock after buying an additional 7,530 shares during the quarter. Woodmont Investment Counsel LLC owned about 0.22% of National Health Investors worth $7,929,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its position in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares during the period. GAMMA Investing LLC raised its position in National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares during the period. Advisory Services Network LLC purchased a new position in National Health Investors in the third quarter valued at about $65,000. Triumph Capital Management purchased a new position in National Health Investors in the third quarter valued at about $66,000. Finally, Farther Finance Advisors LLC raised its position in National Health Investors by 24.9% in the third quarter. Farther Finance Advisors LLC now owns 1,128 shares of the real estate investment trust’s stock valued at $90,000 after purchasing an additional 225 shares during the period. 62.51% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

NHI has been the topic of several research reports. Truist Financial raised their price objective on National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Cantor Fitzgerald set a $85.00 target price on National Health Investors in a research note on Monday, January 5th. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price for the company. in a research note on Tuesday, January 20th. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. Finally, Wells Fargo & Company raised their target price on National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $86.83.

National Health Investors Stock Up 0.5%

NYSE:NHI opened at $84.82 on Thursday. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 28.09, a price-to-earnings-growth ratio of 4.51 and a beta of 0.63. National Health Investors, Inc. has a one year low of $66.41 and a one year high of $91.38. The stock has a 50-day simple moving average of $85.08 and a 200 day simple moving average of $80.04. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90.

National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). The firm had revenue of $105.82 million during the quarter, compared to analyst estimates of $95.12 million. National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $1.24 earnings per share. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Sell-side analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date is Tuesday, March 31st. National Health Investors’s dividend payout ratio (DPR) is 121.85%.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.